Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Abuse Treatment among Perinatal Women
Date & Time
Tuesday, April 3, 2018, 3:45 PM - 5:00 PM
Laura Fanucchi, MD, MPH, Assistant Professor of Medicine, University of Kentucky
Seth S. Himelhoch, MD, MPH, Chair of the Department of Psychiatry, University of Kentucky College of Medicine
Michael G. Kindred, MD, Beyond Birth Medical Director, Surgeon and Addiction Medicine, Assistant Professor, Department of Psychiatry, University of Kentucky College of Medicine
Alice Thornton, MD, Professor of Medicine, University of Kentucky College of Medicine, Chief of the Division of Infectious Diseases, Medical Director, Bluegrass Care Clinic, University of Kentucky Medical Center
Nancy Jennings, BSN, RN, Beyond Birth Nurse Navigator, University of Kentucky HealthCare
Holly Dye, MRC, Beyond Birth Program Director, University of Kentucky HealthCare
Moderator: Mark Birdwhistell, MPA, Vice President for Administration and External Affairs, University of Kentucky HealthCare
CE Certified by: AMA, AAFP, ANCC, NAADAC, NASW, NBCC
Opioid abuse has ravaged the American healthcare landscape, and the Commonwealth of Kentucky is no exception. Kentucky ranks third in the U.S. in overdose deaths. Families residing in Kentucky’s rural communities are disproportionately impacted by the opioid crisis. Although evidence-based medication assisted treatment for opioid dependence exists, resources needed to treat opioid use disorders for women in rural areas are lacking. Between 2000 and 2016, the number of Kentucky babies born with neonatal abstinence syndrome soared exponentially, from 19 to 1,172.
This presentation will describe how UK HealthCare uses family-centered care to treat opioid use disorder as a chronic illness affecting pregnant women and their families during the perinatal period through its’ PATHways Prenatal and Beyond Birth clinic. Patients’ stories will be woven throughout the presentation, highlighting the human aspect of their journeys through a complex healthcare system.
UK HealthCare’s program incorporates the best practices in the field, adhering to federal guidelines for office-based buprenorphine treatment across the spectrum of care for women. The perinatal program provides a comprehensive treatment program for a highly vulnerable subset of the population with substance use disorders. Women and their families are supported and advocated for through continuous levels of care ranging from intensive medical care to sustained recovery. UK HealthCare has office-based opioid treatment programs, which link patients hospitalized with infections related to infectious diseases and chronic infections such as HIV.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Describe how a family-centered approach to substance use treatment can be operationalized across the continuum of care.
- Outline the key components of substance use treatment as it pertains to pregnant and parenting women.
- Identify opportunities for family and stakeholder advocacy in the context of family-centered care.